Kalvista Pharmaceuticals (KALV) Q4 2025 Earnings

Nov 10Confirmed
Q1 2025
Q3 2025
Q3 2025
Q4 2025
-1.12
-0.97
-0.82
-0.67

Details

Expected EPS
-0.672222
Actual EPS
-0.92
Surprise EPS
-0.25
Surprise Percent
-36.86%

Description

⁨Kalvista Pharmaceuticals⁩ (⁦KALV⁩) has reported earnings of ⁦-0.92⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts